Group One Trading
CALT

Group One Trading’s Calliditas Therapeutics AB American Depositary Shares CALT Stock Holding History

Group One Trading’s Portfolio CALT Stock Details CALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,700
Closed -$64.7K – 8333
2023
Q1 		$64.7K Buy
+2,700
New +$53.9K ﹤0.01% 4662
2022
Q1 		– Sell
-900
Closed -$22K – 8900
2021
Q4 		$22K Buy
+900
New +$18.1K ﹤0.01% 6932

Other funds holding CALT

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
IIM
Ironwood Investment Management Boston, Massachusetts $240M AUM 45.82% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Optiver Holding
Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Group One Trading's CALT Position: Q2 2023 in Review

Group One Trading sold out of Calliditas Therapeutics AB American Depositary Shares (CALT) in Q2 2023, closing a stake of 705 shares — an estimated $16.9K sold.

Group One Trading first reported a position in CALT in Q1 2023 and held it in 1 quarter. The position peaked at $16.9K in Q1 2023. 16 funds tracked by Wall St. Rank hold CALT as of Q2 2023.

  • Group One Trading reported no remaining Calliditas Therapeutics AB American Depositary Shares position as of Q2 2023 after selling out during the quarter.
  • Group One Trading sold 705 Calliditas Therapeutics AB American Depositary Shares shares in Q2 2023, an estimated $16.9K.
  • Group One Trading first reported a position in Calliditas Therapeutics AB American Depositary Shares in Q1 2023 and held it in 1 quarter.
  • Group One Trading's Calliditas Therapeutics AB American Depositary Shares position peaked at $16.9K in Q1 2023.
  • 16 funds tracked by Wall St. Rank held Calliditas Therapeutics AB American Depositary Shares as of Q2 2023.

Based on Group One Trading's 13F filing for Q2 2023, filed 9 Aug 2023.